Is the US Party Over?

The country's fading dominance in life sciences research spells trouble for the whole world.

Written byRobert Palazzo
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

If, as Senator Ted Kennedy (D-Mass.) has said, the 21st century will be the "century of the life sciences," the United States should probably be credited with ushering in this phenomenon through a large and deliberate investment in biomedical research, through rapidly increasing the National Institutes of Health budget. More quickly than anyone had initially imagined, the human genome was sequenced, unlocking a wealth of information leading to an exponential growth in research discoveries while laying one of the key pillars for the development of the biotechnology industry. The United States trained a new and much larger generation of scientists. The power of biotechnology, in applications ranging from medical to industrial to agricultural, was unveiled and unleashed.

Perhaps most importantly, we saw a tremendous growth in collaboration across national boundaries. A number of factors have contributed to this increasing international collaboration. Perhaps the simplest is the overarching trend of globalization. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies